Your session is about to expire
← Back to Search
Device
SPRINT® Peripheral Nerve Stimulation (PNS) System (510k Cleared) for Chronic Knee Pain
N/A
Waitlist Available
Led By Einar Ottestad
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected at baseline, 10, 30, 60, and 90 days post lead placement; and 6 months following tka
Awards & highlights
No Placebo-Only Group
Summary
This trial uses the SPRINT PNS System, a device that sends electrical signals to nerves, to help patients with knee pain after knee replacement surgery. The device aims to reduce pain by targeting specific nerves with electrical pulses. If needed, additional signals can be added for better pain relief. The SPRINT PNS System has been used to manage chronic postoperative knee pain by targeting specific nerves with electrical pulses.
Eligible Conditions
- Chronic Knee Pain
- Knee Injuries
- Postoperative Pain
- Chronic Pain
- Peripheral Neuropathy
- Post-Procedural Pain
- Total Knee Replacement
- Surgery
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ collected at baseline, 10, 30, 60, and 90 days post lead placement; and 6 months following tka
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected at baseline, 10, 30, 60, and 90 days post lead placement; and 6 months following tka
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Pain Intensity from Baseline to 12 Months
Secondary study objectives
Change in Opioid Use
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: SPRINT® Peripheral Nerve Stimulation (PNS) SystemExperimental Treatment1 Intervention
SPRINT PNS System will be offered to patients with postoperative knee pain following primary unilateral total knee arthroplasty (TKA) who meet eligibility criteria and consistent with established coverage policy. SPRINT PNS System will be implanted for 60 days. At the discretion of the physician, the first lead may be placed to stimulate the nerve innervating the region of greatest pain. If pain is not adequately addressed by the first lead when assessed at 10 days, a second lead may be placed approximately 2 weeks following the initial lead placement.
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,471 Previous Clinical Trials
17,501,778 Total Patients Enrolled
SPR Therapeutics, Inc.Industry Sponsor
11 Previous Clinical Trials
775 Total Patients Enrolled
Einar OttestadPrincipal Investigator - CLINICAL ASSOCIATE PROFESSOR, ANESTHESIOLOGY, PERIOPERATIVE AND PAIN MEDICINE
Baylor College Of Medicine (Medical School)
Stanford University Hospital (Residency)
Share this study with friends
Copy Link
Messenger